Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back

The Drug-Induced Respiratory Disease Website and App

I.v

I - Interstitial/parenchymal lung disease

Relapsing or migrating pneumonitis/pneumonia (see also Id)

Last update 17/06/2026

Relapsing episodes of pneumonitis or areas of consolidation on 1-continued exposure to the drug, 2-following patient rechallenge, or 3-following drug discontinuance ('aftershock') may occur, especially following corticosteroid taper or withdrawal (PMID 30572331°. Amiodarone, statins and immune chekpoints can produce episodes of relapsing pneumonitis or BOOP, even though the drug has been discontinued 5pmid 30572331°

Causative drugs

7

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Amiodarone
I.a
I.b
I.c
I.d
I.e
I.f
I.g
I.i
I.l
I.m
I.t
I.v
I.x
I.aa
I.ab
I.ap
I.au
I.ay
I.az
II.e
II.m
III.a
III.c
IV.a
IV.k
IV.ab
V.a
VI.a
VI.c
VI.d
VI.u
VII.a
VII.i
IX.a
IX.d
IX.ai
X.d
X.f
X.s
XI.c
XI.g
XII.a
XII.c
XII.f
XII.n
XII.o
XII.q
XII.v
XII.ah
XII.aw
XV.g
XVI.b
XVI.i
XVI.j
XVI.n
XVI.s
XVI.w
XVI.x
XVI.ab
XVI.ac
XVI.ba
XVI.bb
XVI.bn
XVI.bt
XVI.bv
XVI.cb
XVII.b
XVII.j
XVII.k
XVII.p
XVIII.a
XVIII.b
XVIII.c
XVIII.e
XVIII.f
XVIII.m
XVIII.p
XIX.a
XIX.b
XIX.c
XIX.d
XIX.e
XIX.k
XIX.o
XIX.q
XIX.r
XIX.v
XIX.w
XIX.aa
XIX.ae
XIX.ag
XIX.aj
XIX.ak
XIX.bm
XX.e
Beta-blockers
I.a
I.b
I.c
I.e
I.g
I.v
II.a
IV.a
IV.b
IV.c
IV.d
VI.a
VI.c
VI.d
VII.v
IX.d
X.d
X.aa
XI.o
XI.ac
XII.o
XII.u
XII.ah
E-cigarette - E-vaporizers - ENDS - Vaping - Dabbing
I.a
I.b
I.c
I.d
I.e
I.f
I.k
I.n
I.o
I.v
I.w
I.ax
I.ay
II.e
II.u
III.a
III.c
III.m
IV.a
IV.b
IV.e
IV.h
IV.j
IV.l
IV.p
IV.u
IV.ab
IV.af
IV.ag
V.i
V.p
V.am
V.ao
V.aq
V.av
V.ax
V.az
VI.a
VI.f
VIII.a
VIII.e
VIII.h
IX.h
IX.af
X.b
X.m
X.s
X.as
XI.b
XI.o
XI.z
XI.at
XI.aw
XI.ax
XI.ay
XII.a
XII.n
XII.ai
XIV.a
XVI.a
XVI.b
XVI.d
XVI.g
XVI.k
XVI.v
XVI.ad
XVI.ak
XVI.bp
XVII.x
XVIII.a
XVIII.b
XVIII.c
XVIII.d
XVIII.f
XVIII.i
XVIII.n
XIX.d
XIX.e
XIX.f
XIX.l
XIX.o
XIX.r
XIX.z
XIX.al
XIX.ap
XIX.bc
XIX.bx
XX.a
XX.c
XX.h
XX.ab
Immune checkpoint inhibitors (ICI) - ICI combinatorial Rx
I.a
I.b
I.c
I.d
I.e
I.f
I.g
I.v
I.w
I.x
I.z
I.ab
I.ae
I.ak
I.ay
II.b
II.e
III.m
IV.a
IV.d
IV.t
IV.x
IV.af
IV.ag
V.g
VI.a
VI.i
VI.t
VII.a
VII.b
VIII.a
IX.a
IX.d
IX.r
IX.ab
IX.ac
X.a
X.c
X.d
X.e
X.f
X.i
X.j
X.l
X.m
X.o
X.p
X.u
X.w
X.ao
X.ap
X.ax
X.az
X.bj
XI.l
XI.v
XI.ad
XI.ar
XI.as
XI.av
XII.a
XII.c
XII.d
XII.f
XII.h
XII.n
XII.o
XII.s
XII.t
XII.ak
XII.az
XII.bd
XVI.k
XVI.v
XVI.w
XVI.bj
XVI.bk
XVI.bv
XVIII.a
XVIII.b
XVIII.c
XIX.a
XIX.b
XIX.d
XIX.e
XIX.f
XIX.j
XIX.o
XIX.x
XIX.ae
XIX.al
XIX.bx
XIX.co
XIX.cr
XIX.cv
XX.b
XX.c
XX.e
XX.g
XX.q
XX.r
Radiation therapy to the breast
I.a
I.c
I.e
I.i
I.p
I.v
I.w
I.aa
VI.u
XII.b
XII.c
XII.p
XVI.i
XVIII.a
XIX.d
XXI.a
XXI.m
Sotalol
I.e
I.v
IV.a
Statins
I.a
I.b
I.e
I.f
I.g
I.v
I.y
I.ar
I.as
IV.ab
V.a
VI.a
VI.b
VI.d
VI.h
IX.a
IX.ac
X.d
X.l
X.bb
XI.b
XII.ad
XVI.x
XVIII.f
XIX.d
XIX.e
XIX.v
XIX.aa
XIX.ae
XIX.br